Want to see JP:3645 full AI Analyst Report?

Medical Net,Inc. (3645) Ratios

0 Followers

Medical Net,Inc. Ratios

JP:3645's free cash flow for Q4 2025 was ¥0.29. For the 2025 fiscal year, JP:3645's free cash flow was decreased by ¥ and operating cash flow was ¥0.04. See a summary of the company’s cash flow.

Ratios	TTM	May 25	May 24	May 23	May 22
Liquidity Ratios
Current Ratio	1.64	1.64	1.53	1.75	1.71
Quick Ratio	1.48	1.48	1.37	1.62	1.62
Cash Ratio	0.89	0.89	0.75	0.94	1.06
Solvency Ratio	0.09	0.09	<0.01	0.03	0.12
Operating Cash Flow Ratio	0.05	0.05	-0.04	0.07	0.30
Short-Term Operating Cash Flow Coverage	0.09	0.09	-0.09	0.19	0.61
Net Current Asset Value	¥ 1.10B	¥ 1.10B	¥ 646.39M	¥ 777.32M	¥ 921.23M
Leverage Ratios
Debt-to-Assets Ratio	0.31	0.31	0.31	0.26	0.23
Debt-to-Equity Ratio	0.71	0.71	0.73	0.54	0.41
Debt-to-Capital Ratio	0.42	0.42	0.42	0.35	0.29
Long-Term Debt-to-Capital Ratio	0.12	0.12	0.16	0.17	0.04
Financial Leverage Ratio	2.29	2.29	2.38	2.09	1.81
Debt Service Coverage Ratio	0.15	0.14	0.12	0.13	0.24
Interest Coverage Ratio	12.00	11.66	8.16	46.45	125.46
Debt to Market Cap	0.60	0.58	0.44	0.31	0.22
Interest Debt Per Share	153.17	156.55	142.20	114.52	88.59
Net Debt to EBITDA	-1.98	-2.02	-1.16	-2.34	-2.30
Profitability Margins
Gross Profit Margin	29.66%	29.60%	32.28%	35.05%	39.57%
EBIT Margin	2.85%	2.77%	1.55%	3.04%	5.64%
EBITDA Margin	4.00%	3.93%	2.81%	4.06%	7.02%
Operating Profit Margin	2.85%	2.77%	1.55%	5.68%	8.44%
Pretax Profit Margin	3.85%	3.86%	0.41%	2.91%	5.57%
Net Profit Margin	2.04%	2.04%	-1.12%	0.11%	2.58%
Continuous Operations Profit Margin	2.42%	2.43%	-0.62%	0.50%	2.42%
Net Income Per EBT	53.01%	53.01%	-270.55%	3.89%	46.33%
EBT Per EBIT	135.32%	139.26%	26.72%	51.31%	66.05%
Return on Assets (ROA)	3.01%	3.01%	-1.67%	0.15%	3.35%
Return on Equity (ROE)	7.05%	6.90%	-3.97%	0.31%	6.06%
Return on Capital Employed (ROCE)	8.06%	7.83%	4.39%	12.60%	18.71%
Return on Invested Capital (ROIC)	3.41%	3.32%	-4.59%	1.71%	6.02%
Return on Tangible Assets	3.31%	3.31%	-1.87%	0.17%	3.67%
Earnings Yield	5.72%	5.56%	-2.41%	0.18%	3.30%
Efficiency Ratios
Receivables Turnover	6.42	6.42	6.87	6.30	6.67
Payables Turnover	11.90	11.90	10.05	7.82	8.42
Inventory Turnover	13.01	13.01	12.91	16.53	21.94
Fixed Asset Turnover	58.62	58.58	45.59	41.83	40.39
Asset Turnover	1.47	1.47	1.49	1.32	1.30
Working Capital Turnover Ratio	4.84	5.52	5.42	4.70	5.00
Cash Conversion Cycle	54.20	54.25	45.08	33.35	28.00
Days of Sales Outstanding	56.82	56.86	53.10	57.95	54.70
Days of Inventory Outstanding	28.06	28.06	28.28	22.08	16.64
Days of Payables Outstanding	30.67	30.67	36.30	46.68	43.34
Operating Cycle	84.87	84.92	81.38	80.03	71.34
Cash Flow Ratios
Operating Cash Flow Per Share	10.52	10.76	-9.06	13.22	47.89
Free Cash Flow Per Share	9.53	9.74	-23.80	9.59	45.59
CapEx Per Share	0.99	1.01	14.74	3.63	2.30
Free Cash Flow to Operating Cash Flow	0.91	0.91	2.63	0.73	0.95
Dividend Paid and CapEx Coverage Ratio	2.74	2.74	-0.51	2.16	7.69
Capital Expenditure Coverage Ratio	10.62	10.62	-0.61	3.65	20.80
Operating Cash Flow Coverage Ratio	0.07	0.07	-0.06	0.12	0.54
Operating Cash Flow to Sales Ratio	0.01	0.01	-0.01	0.02	0.10
Free Cash Flow Yield	3.78%	3.62%	-7.51%	2.61%	11.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	17.17	17.98	-41.49	558.59	30.31
Price-to-Sales (P/S) Ratio	0.35	0.37	0.47	0.63	0.78
Price-to-Book (P/B) Ratio	1.21	1.24	1.65	1.75	1.84
Price-to-Free Cash Flow (P/FCF) Ratio	26.44	27.61	-13.32	38.35	8.62
Price-to-Operating Cash Flow Ratio	24.32	25.01	-34.99	27.83	8.21
Price-to-Earnings Growth (PEG) Ratio	<0.01	-0.06	0.03	-5.89	-0.43
Price-to-Fair Value	1.21	1.24	1.65	1.75	1.84
Enterprise Value Multiple	6.80	7.34	15.39	13.27	8.85
Enterprise Value	1.83B	1.94B	2.63B	2.83B	2.79B
EV to EBITDA	6.80	7.34	15.39	13.27	8.85
EV to Sales	0.27	0.29	0.43	0.54	0.62
EV to Free Cash Flow	20.48	21.64	-12.38	32.61	6.84
EV to Operating Cash Flow	18.55	19.61	-32.53	23.66	6.51
Tangible Book Value Per Share	175.46	179.33	150.23	162.69	181.13
Shareholders’ Equity Per Share	212.28	216.97	192.26	210.85	213.93
Tax and Other Ratios
Effective Tax Rate	0.37	0.37	2.49	0.83	0.57
Revenue Per Share	716.79	732.02	680.32	580.64	502.28
Net Income Per Share	14.64	14.96	-7.64	0.66	12.97
Tax Burden	0.53	0.53	-2.71	0.04	0.46
Interest Burden	1.35	1.39	0.27	0.96	0.99
Research & Development to Revenue	0.00	0.00	<0.01	<0.01	0.00
SG&A to Revenue	0.27	0.27	0.30	0.03	0.03
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.72	0.72	1.19	20.07	3.70

Currency in JPY